CN102066353B - 二取代的酞嗪Hedgehog通路拮抗剂 - Google Patents

二取代的酞嗪Hedgehog通路拮抗剂 Download PDF

Info

Publication number
CN102066353B
CN102066353B CN2009801152085A CN200980115208A CN102066353B CN 102066353 B CN102066353 B CN 102066353B CN 2009801152085 A CN2009801152085 A CN 2009801152085A CN 200980115208 A CN200980115208 A CN 200980115208A CN 102066353 B CN102066353 B CN 102066353B
Authority
CN
China
Prior art keywords
trifluoromethyl
compound
pharmaceutically acceptable
acceptable salt
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009801152085A
Other languages
English (en)
Chinese (zh)
Other versions
CN102066353A (zh
Inventor
P·A·希普斯金德
T·威尔逊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of CN102066353A publication Critical patent/CN102066353A/zh
Application granted granted Critical
Publication of CN102066353B publication Critical patent/CN102066353B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN2009801152085A 2008-04-29 2009-04-01 二取代的酞嗪Hedgehog通路拮抗剂 Expired - Fee Related CN102066353B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4872908P 2008-04-29 2008-04-29
US61/048,729 2008-04-29
PCT/US2009/039065 WO2009134574A2 (en) 2008-04-29 2009-04-01 Disubstituted phthalazine hedgehog pathway antagonists

Publications (2)

Publication Number Publication Date
CN102066353A CN102066353A (zh) 2011-05-18
CN102066353B true CN102066353B (zh) 2013-12-11

Family

ID=40846962

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801152085A Expired - Fee Related CN102066353B (zh) 2008-04-29 2009-04-01 二取代的酞嗪Hedgehog通路拮抗剂

Country Status (22)

Country Link
US (1) US7981892B2 (https=)
EP (1) EP2294061A2 (https=)
JP (1) JP5442717B2 (https=)
KR (1) KR101260116B1 (https=)
CN (1) CN102066353B (https=)
AU (1) AU2009241561B2 (https=)
BR (1) BRPI0911618A2 (https=)
CA (1) CA2723042A1 (https=)
CO (1) CO6300945A2 (https=)
CR (1) CR11741A (https=)
DO (1) DOP2010000302A (https=)
EA (1) EA201071248A1 (https=)
EC (1) ECSP10010577A (https=)
HN (1) HN2010002157A (https=)
IL (1) IL208211A0 (https=)
MA (1) MA32349B1 (https=)
MX (1) MX2010011948A (https=)
MY (1) MY159491A (https=)
NZ (1) NZ588001A (https=)
UA (1) UA102250C2 (https=)
WO (1) WO2009134574A2 (https=)
ZA (1) ZA201006695B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA102250C2 (ru) 2008-04-29 2013-06-25 Эли Лилли Энд Компани Двухзамещенные фталазины - антагонисты проводящего пути hedgehog
MX2011004683A (es) 2008-11-03 2011-06-20 Lilly Co Eli Antagonistas de la via hedgehog de ftalazina disustituida.
KR101342184B1 (ko) 2008-11-17 2013-12-19 일라이 릴리 앤드 캄파니 사치환된 피리다진 헷지호그 경로 길항제
BRPI0921777A2 (pt) 2008-11-17 2016-01-12 Lilly Co Eli antagonistas da via hedgehog de piridazina tetrassubstituída
AR077014A1 (es) * 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
KR20120107962A (ko) * 2009-11-18 2012-10-04 노파르티스 아게 고형 종양 및 다른 악성종양의 치료를 위한 방법 및 조성물
CN102702108A (zh) * 2012-06-27 2012-10-03 上海大学 1,2-二氢酞嗪类化合物及其合成方法
WO2014043608A2 (en) * 2012-09-17 2014-03-20 Duke University Smoothened modulators and methods of use thereof
CN102863393A (zh) * 2012-09-26 2013-01-09 上海大学 1,2-二氢酞嗪类化合物及其合成方法
GB201309508D0 (en) * 2013-05-28 2013-07-10 Redx Pharma Ltd Compounds
GB2528298A (en) * 2014-07-16 2016-01-20 Redx Pharma Plc Compounds
CN105985320B (zh) * 2015-02-11 2018-10-26 复旦大学 苄基酞嗪化合物及其制备方法和用途
CN105985319B (zh) * 2015-02-11 2019-02-26 复旦大学 芳基酞嗪化合物及其制备方法和用途
CN105985321B (zh) * 2015-02-11 2018-10-26 复旦大学 吡唑酞嗪化合物及其制备方法和用途
CN107163028B (zh) * 2017-05-24 2019-07-12 东南大学 一种苯甲酰胺类Hedgehog抑制剂及其制备方法和应用
US12605377B2 (en) 2020-10-13 2026-04-21 Endeavor Biomedicines, Inc. Methods of treating fibrosis
JP2023546536A (ja) 2020-10-13 2023-11-02 エンデバー バイオメディシンズ， インコーポレイテッド 線維症を処置する方法
IL319619A (en) * 2022-09-23 2025-05-01 Merck Sharp & Dohme Llc Phthalazine derivatives used as NOD-LIKE PROTEIN 3 receptor inhibitors
WO2025188802A1 (en) 2024-03-05 2025-09-12 Endeavor Biomedicines, Inc. Methods of improving lung function

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005033288A2 (en) * 2003-09-29 2005-04-14 The Johns Hopkins University Hedgehog pathway antagonists
WO2006028958A2 (en) * 2004-09-02 2006-03-16 Genentech, Inc. Pyridyl inhibitors of hedgehog signalling

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1293565A (en) * 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
MY117098A (en) * 1996-01-15 2004-05-31 Janssen Pharmaceutica Nv Angiogenesis inhibiting pyridazinamines
US6432970B2 (en) * 1998-04-09 2002-08-13 Johns Hopkins University School Of Medicine Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
JP5067986B2 (ja) 1998-04-09 2012-11-07 ジョンズ ホプキンズ ユニヴァーシティー スクール オブ メディシン ヘッジホッグシグナリング経路の阻害剤としてのステロイドアルカロイド誘導体の使用
ATE283700T1 (de) 1999-06-08 2004-12-15 Lorantis Ltd Therapeutische verwendung eines inhibitors des hedgehog signalübertragungsweges
EP1496905B1 (en) 2002-04-22 2008-08-13 Johns Hopkins University School of Medicine Modulators of hedgehog signaling pathways, compositions and uses related thereto
WO2004020599A2 (en) 2002-08-29 2004-03-11 Curis, Inc. Hedgehog antagonists, methods and uses related thereto
TW200533356A (en) 2004-02-24 2005-10-16 Mitsubishi Pharma Corp Fused pyridazine derivatives
WO2006004589A2 (en) 2004-05-08 2006-01-12 Neurogen Corporation 3-aryl-5,6-disubstituted pyridazines
EP1900731A1 (de) 2006-09-07 2008-03-19 Bayer Schering Pharma Aktiengesellschaft N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren
CA2681162C (en) 2007-03-15 2015-11-24 Novartis Ag Benzyl and pyridine derivatives as modulators of hedgehog pathway
US8153633B2 (en) * 2007-06-25 2012-04-10 Amgen Inc. Phthalazine compounds, compositions and methods of use
US8222251B2 (en) 2007-09-07 2012-07-17 Amgen Inc. Pyridopyridazine compounds, compositions and methods of use
UA102250C2 (ru) 2008-04-29 2013-06-25 Эли Лилли Энд Компани Двухзамещенные фталазины - антагонисты проводящего пути hedgehog
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors
MX2011004683A (es) 2008-11-03 2011-06-20 Lilly Co Eli Antagonistas de la via hedgehog de ftalazina disustituida.
BRPI0921777A2 (pt) 2008-11-17 2016-01-12 Lilly Co Eli antagonistas da via hedgehog de piridazina tetrassubstituída
KR101342184B1 (ko) 2008-11-17 2013-12-19 일라이 릴리 앤드 캄파니 사치환된 피리다진 헷지호그 경로 길항제
AR077014A1 (es) * 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005033288A2 (en) * 2003-09-29 2005-04-14 The Johns Hopkins University Hedgehog pathway antagonists
WO2006028958A2 (en) * 2004-09-02 2006-03-16 Genentech, Inc. Pyridyl inhibitors of hedgehog signalling

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WO2006028958A2A2 2006.03.16

Also Published As

Publication number Publication date
CA2723042A1 (en) 2009-11-05
CR11741A (es) 2011-01-05
EA201071248A1 (ru) 2011-06-30
MX2010011948A (es) 2010-12-14
MY159491A (en) 2017-01-13
AU2009241561A1 (en) 2009-11-05
CN102066353A (zh) 2011-05-18
US7981892B2 (en) 2011-07-19
NZ588001A (en) 2012-06-29
UA102250C2 (ru) 2013-06-25
JP2011527666A (ja) 2011-11-04
ECSP10010577A (es) 2010-11-30
EP2294061A2 (en) 2011-03-16
WO2009134574A3 (en) 2014-09-04
KR101260116B1 (ko) 2013-05-02
WO2009134574A2 (en) 2009-11-05
US20110046143A1 (en) 2011-02-24
HN2010002157A (es) 2014-09-08
ZA201006695B (en) 2012-09-26
CO6300945A2 (es) 2011-07-21
KR20100126580A (ko) 2010-12-01
AU2009241561B2 (en) 2013-05-16
DOP2010000302A (es) 2010-11-15
MA32349B1 (fr) 2011-06-01
IL208211A0 (en) 2010-12-30
JP5442717B2 (ja) 2014-03-12
BRPI0911618A2 (pt) 2019-09-24

Similar Documents

Publication Publication Date Title
CN102066353B (zh) 二取代的酞嗪Hedgehog通路拮抗剂
JP5518887B2 (ja) 四置換ピリダジンヘッジホッグ経路アンタゴニスト
CN102459233B (zh) 二取代的酞嗪hedgehog途径拮抗剂
CN101341149B (zh) 经色原烷取代的苯并咪唑类和它们作为酸泵抑制剂的用途
CN102202737B (zh) 二取代的2,3-二氮杂萘hedgehog通路拮抗剂
CN110621317B (zh) 组蛋白去乙酰化酶（hdacs）抑制剂
ES2446307T3 (es) Piridazinas tetrasustituidas antagonistas de la ruta de Hedgehog
CN100402523C (zh) 杂环化合物及以其为有效成分的抗肿瘤药
WO2007142323A1 (ja) 側鎖にスピロ環構造を有する新規インダゾール誘導体
JP2007519692A (ja) ｐ３８キナーゼ阻害剤として使用するための縮合ヘテロアリール誘導体
CN1956954B (zh) 新的雄激素
CN113801062B (zh) 3-氨基-5-(3,5-二氟苄基)-1h-吲唑的制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20131211

Termination date: 20150401

EXPY Termination of patent right or utility model